These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16600170)

  • 1. Studies on genomic DNA topology and stability in brain regions of Parkinson's disease.
    Hegde ML; Gupta VB; Anitha M; Harikrishna T; Shankar SK; Muthane U; Subba Rao K; Jagannatha Rao KS
    Arch Biochem Biophys; 2006 May; 449(1-2):143-56. PubMed ID: 16600170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular studies on Abeta(42) induced genomic instability in aged rabbit brain.
    Narasingappa RB; Prahalad RK; Mannar SS; Sathyanarayana RT; Hanumanthappa BK; Jagannatha RK
    Neurochem Int; 2010 Apr; 56(5):655-62. PubMed ID: 20117159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
    Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
    Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease.
    Cerasa A; Hagberg GE; Peppe A; Bianciardi M; Gioia MC; Costa A; Castriota-Scanderbeg A; Caltagirone C; Sabatini U
    Brain Res Bull; 2006 Dec; 71(1-3):259-69. PubMed ID: 17113955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability.
    Pieper HC; Evert BO; Kaut O; Riederer PF; Waha A; Wüllner U
    Neurobiol Dis; 2008 Dec; 32(3):521-7. PubMed ID: 18930140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium, magnesium and aluminum concentrations in Parkinson's disease.
    Yasui M; Kihira T; Ota K
    Neurotoxicology; 1992; 13(3):593-600. PubMed ID: 1475063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M; Kondo T; Mizuno Y; Nagatsu T
    Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.
    Vogt IR; Lees AJ; Evert BO; Klockgether T; Bonin M; Wüllner U
    Exp Neurol; 2006 Jun; 199(2):465-78. PubMed ID: 16626704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
    Chiba-Falek O; Lopez GJ; Nussbaum RL
    Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson's disease.
    Arai T; Fukae J; Hatano T; Kubo S; Ohtsubo T; Nakabeppu Y; Mori H; Mizuno Y; Hattori N
    Acta Neuropathol; 2006 Aug; 112(2):139-45. PubMed ID: 16773329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coenzyme Q10 status of the brain regions of Parkinson's disease patients.
    Hargreaves IP; Lane A; Sleiman PM
    Neurosci Lett; 2008 Dec; 447(1):17-9. PubMed ID: 18840506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
    Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
    Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved asymmetry of gait in Parkinson's disease with DBS: gait and postural instability in Parkinson's disease treated with bilateral deep brain stimulation in the subthalamic nucleus.
    Johnsen EL; Mogensen PH; Sunde NA; Østergaard K
    Mov Disord; 2009 Mar; 24(4):590-7. PubMed ID: 19097189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genome hybridization array analysis for sporadic Parkinson's disease.
    Kim JS; Yoo JY; Lee KS; Kim HS; Choi JS; Rha HK; Yim SV; Lee KH
    Int J Neurosci; 2008 Sep; 118(9):1331-45. PubMed ID: 18698514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease.
    Baloyannis SJ; Costa V; Baloyannis IS
    J Neurol Sci; 2006 Oct; 248(1-2):35-41. PubMed ID: 16753180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease.
    Wu T; Wang L; Chen Y; Zhao C; Li K; Chan P
    Neurosci Lett; 2009 Aug; 460(1):6-10. PubMed ID: 19463891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.
    Martin WR; Wieler M; Gee M
    Neurology; 2008 Apr; 70(16 Pt 2):1411-7. PubMed ID: 18172063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.